Back to search
FDAFDA · Food and drugs·Recall number Z-1979-2019

The Tina-quant lgA Gen.2 is an immunoturbidimetric assay. Anti-lgA antibodies react with antigen in the sample to form an antigen/antibody complex which is measured turbidimetrically.

Published July 24, 2019 · Recall initiated: June 3, 2019

Summary

FDA records medical device Class II recall Z-1979-2019, published July 24, 2019 and initiated June 3, 2019. Recalling firm: Roche Diagnostics Corporation; Status: Terminated; Reported quantity: 8 units; Lot: Lot 368756. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Calibration failures with Std.E, Sens.E, or Dup.E error due to atypical reaction kinetics and quality control failures have occurred due to contamination of R1 reagent with R3 reagent.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Roche Diagnostics Corporation
Distributor
The products were distributed to the following US states: AL, IN, and KY.
Lot
Lot 368756
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was The Tina-quant lgA Gen.2 is an immunoturbidimetric assay. Anti-lgA antibodies react with antigen in the sample to form an antigen/antibody complex which is measured turbidimetrically. recalled?

Yes. FDA published recall Z-1979-2019 on July 24, 2019. Reported hazard: Calibration failures with Std.E, Sens.E, or Dup.E error due to atypical reaction kinetics and quality control failures have occurred due to contamination of R1 reagent with R3 reagent.

What should I do if I have this product?

Voluntary: Firm initiated · Letter